Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126401621 | 12640162 | 1 | I | 201605 | 20160728 | 20160810 | 20160810 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-49732BP | BOEHRINGER INGELHEIM | 84.73 | YR | F | Y | 0.00000 | 20160810 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126401621 | 12640162 | 1 | PS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 150 MG | 560605 | 21698 | 150 | MG | TABLET | QD | |||||
| 126401621 | 12640162 | 2 | C | GAVISCON | ALUMINUM HYDROXIDEMAGNESIUM CARBONATE | 1 | Unknown | 0 | |||||||||||
| 126401621 | 12640162 | 3 | C | MYLANTA | ALUMINUM HYDROXIDEDIMETHICONEMAGNESIUM HYDROXIDE | 1 | Unknown | 0 | |||||||||||
| 126401621 | 12640162 | 4 | C | TUMS | CALCIUM CARBONATE | 1 | Unknown | 0 | |||||||||||
| 126401621 | 12640162 | 5 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 2 NR | 0 | QD | |||||||||
| 126401621 | 12640162 | 6 | C | ZEGERID | OMEPRAZOLESODIUM BICARBONATE | 1 | Unknown | 0 | |||||||||||
| 126401621 | 12640162 | 7 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | 1 NR | 0 | QD | |||||||||
| 126401621 | 12640162 | 8 | C | PROBIOTICS | PROBIOTICS NOS | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126401621 | 12640162 | 1 | Gastrooesophageal reflux disease |
| 126401621 | 12640162 | 2 | Gastrooesophageal reflux disease |
| 126401621 | 12640162 | 3 | Gastrooesophageal reflux disease |
| 126401621 | 12640162 | 4 | Gastrooesophageal reflux disease |
| 126401621 | 12640162 | 5 | Hypertension |
| 126401621 | 12640162 | 6 | Gastrooesophageal reflux disease |
| 126401621 | 12640162 | 7 | Anxiety |
| 126401621 | 12640162 | 8 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126401621 | 12640162 | Medication error | |
| 126401621 | 12640162 | Oesophageal pain | |
| 126401621 | 12640162 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126401621 | 12640162 | 1 | 201605 | 0 |